LIDOCAINE 2% / MUPIROCIN 2% ointment

Country: Amerika Syarikat

Bahasa: Inggeris

Sumber: NLM (National Library of Medicine)

Bahan aktif:

MUPIROCIN (UNII: D0GX863OA5) (MUPIROCIN - UNII:D0GX863OA5), LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987)

Boleh didapati daripada:

Sincerus Florida, LLC

Laluan pentadbiran:

TOPICAL

Jenis preskripsi:

PRESCRIPTION DRUG

Status kebenaran:

unapproved drug other

Ciri produk

LIDOCAINE 2% / MUPIROCIN 2%- LIDOCAINE 2% / MUPIROCIN 2% OINTMENT
SINCERUS FLORIDA, LLC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
LIDOCAINE 2% / MUPIROCIN 2%
DIRECTIONS FOR USE
SINCERUS FLORIDA, LLC. ADVERSE REACTIONS
ACTIVE, INACTIVE
NDC 72934- 5139-2 LIDOCAINE 2% / MUPIROCIN 2%. OINTMENT 30GM.
LIDOCAINE 2% / MUPIROCIN 2%
lidocaine 2% / mupirocin 2% ointment
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN PRESCRIPTION DRUG
ITE M CODE (SOURCE )
NDC:729 34-5139
ROUTE OF ADMINISTRATION
TOPICAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
MUPIRO CIN (UNII: D0 GX8 6 3OA5) (MUPIROCIN - UNII:D0 GX8 6 3OA5)
MUPIROCIN
2 g in 10 0 g
LIDO CAINE (UNII: 9 8 PI20 0 9 8 7) (LIDOCAINE - UNII:9 8 PI20 0 9 8
7)
LIDOCAINE
2 g in 10 0 g
Sincerus Florida, LLC
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START
DATE
MARKETING END DATE
1
NDC:729 34-5139 -
2
30 g in 1 BOTTLE, PUMP; Type 0 : No t a Co mbinatio n
Pro duc t
0 5/15/20 19
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
0 5/15/20 19
LABELER -
Sincerus Florida, LLC (080105003)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSINE SS OPE RATIONS
Sincerus Flo rida, LLC
0 8 0 10 50 0 3
ma nufa c ture (729 34-5139 )
Revised: 5/2019